These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8123474

  • 21. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
    Tóth G, Schlammadinger J, Aradi J, Antal-Szalmás P, Sipka S, Balázs M, Kovács P, Fehér Z, Falus A.
    Cell Biol Int; 2004; 28(11):817-23. PubMed ID: 15563404
    [Abstract] [Full Text] [Related]

  • 22. Integrin receptor-targeted transfer peptides for efficient delivery of antisense oligodeoxynucleotides.
    Bachmann AS, Surovoy A, Jung G, Moelling K.
    J Mol Med (Berl); 1998 Feb; 76(2):126-32. PubMed ID: 9500678
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Anti-proliferative effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: use of poly (lysine/serine) copolymers or cationic lipopolyamines.
    Aoki Y, Kawa S, Karasawa Y, Horiuchi A, Kiyosawa K.
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):702-5. PubMed ID: 9750959
    [Abstract] [Full Text] [Related]

  • 25. The proto-oncogene c-myb mediates an intracellular calcium rise during the late G1 phase of the cell cycle.
    Simons M, Morgan KG, Parker C, Collins E, Rosenberg RD.
    J Biol Chem; 1993 Jan 05; 268(1):627-32. PubMed ID: 8416967
    [Abstract] [Full Text] [Related]

  • 26. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S, Skorski T, Cucco C, Nieborowska-Skorska M, Chiu CY, Lloyd D, Chen JK, Koziolkiewicz M, Calabretta B.
    Nucleic Acids Res; 1996 Apr 15; 24(8):1508-14. PubMed ID: 8628685
    [Abstract] [Full Text] [Related]

  • 27. Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.
    Venturelli D, Mariano MT, Szczylik C, Valtieri M, Lange B, Crist W, Link M, Calabretta B.
    Cancer Res; 1990 Nov 15; 50(22):7371-5. PubMed ID: 2224864
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
    Melani C, Rivoltini L, Parmiani G, Calabretta B, Colombo MP.
    Cancer Res; 1991 Jun 01; 51(11):2897-901. PubMed ID: 2032228
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Specifically designed polymeric nanospheres increase cellular uptake of unmodified antisense ODNs.
    Tondelli L, Laus M, Ricca A, Citro G.
    Nucleosides Nucleotides; 1999 Jun 01; 18(6-7):1677-9. PubMed ID: 10474244
    [Abstract] [Full Text] [Related]

  • 31. Growth inhibition of human leukemia HL-60 cells by an antisense phosphodiester oligonucleotide encapsulated into fusogenic liposomes.
    Kondoh M, Matsuyama T, Suzuki R, Mizuguchi H, Nakanishi T, Nakagawa S, Tsutsumi Y, Nakanishi M, Sato M, Mayumi T.
    Biol Pharm Bull; 2000 Aug 01; 23(8):1011-3. PubMed ID: 10963315
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG, Joshi SS, Chan WC, Iversen PL, Jackson JD, Kessinger A, Pirruccello SJ, Sanger WG, Sharp JG, Verbik DJ.
    Leuk Lymphoma; 1995 Dec 01; 20(1-2):67-76. PubMed ID: 8750625
    [Abstract] [Full Text] [Related]

  • 35. Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1.
    Moon IJ, Choi K, Choi YK, Kim JE, Lee Y, Schreiber AD, Park JG.
    J Biol Chem; 2000 Feb 18; 275(7):4647-53. PubMed ID: 10671493
    [Abstract] [Full Text] [Related]

  • 36. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines.
    Guerra J, Withers DA, Boxer LM.
    Blood; 1995 Sep 01; 86(5):1873-80. PubMed ID: 7655015
    [Abstract] [Full Text] [Related]

  • 37. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.
    Reiss K, Porcu P, Sell C, Pietrzkowski Z, Baserga R.
    Oncogene; 1992 Nov 01; 7(11):2243-8. PubMed ID: 1359494
    [Abstract] [Full Text] [Related]

  • 38. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C, Calabretta B.
    Cancer Res; 1996 Oct 01; 56(19):4332-7. PubMed ID: 8813118
    [Abstract] [Full Text] [Related]

  • 39. Dissociation between p93B-myb and p75c-myb expression during the proliferation and differentiation of human myeloid cell lines.
    Arsura M, Luchetti MM, Erba E, Golay J, Rambaldi A, Introna M.
    Blood; 1994 Apr 01; 83(7):1778-90. PubMed ID: 8142646
    [Abstract] [Full Text] [Related]

  • 40. Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes.
    Reddy MA, Yang BS, Yue X, Barnett CJ, Ross IL, Sweet MJ, Hume DA, Ostrowski MC.
    J Exp Med; 1994 Dec 01; 180(6):2309-19. PubMed ID: 7964503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.